Epidemiology and clinical outcomes of multidrug-resistant, Gram-negative bloodstream infections in a European tertiary pediatric hospital during a 12-month period

Pediatric Infectious Disease Journal

Volumn 33, Issue 9, 2014, Pages 929-932

  Folgori, Laura ^a   Livadiotti, Susanna ^a   Carletti, Michaela ^b   Bielicki, Julia ^c   Pontrelli, Giuseppe ^a   Atti, Marta Luisa Ciofi Degli ^b   Bertaina, Chiara ^a   Lucignano, Barbara ^b   Ranno, Stefania ^b   Carretto, Edoardo ^d   Muraca, Maurizio ^b   Sharland, Mike ^c   Bernaschi, Paola ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BLOOD CULTURE; BLOODSTREAM INFECTION; CHILD; CITROBACTER; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE SEPSIS; HOSPITAL ADMISSION; HUMAN; INFECTION RATE; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANT GRAM NEGATIVE SEPSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SERRATIA MARCESCENS; STENOTROPHOMONAS MALTOPHILIA; CROSS INFECTION; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITAL; INCIDENCE; INFANT; ITALY; LENGTH OF STAY; MICROBIOLOGY; MULTIDRUG RESISTANCE; NEWBORN; PRESCHOOL CHILD; TERTIARY CARE CENTER;

BACTEREMIA; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS, PEDIATRIC; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MALE; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; ROME; TERTIARY CARE CENTERS;

EID: 84926199426     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000339     Document Type: Article

References (30)

1. Diekema DJ, Pfaller MA, Jones RN, et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clin Infect Dis. 1999;29:595-607.
2. Khan FY, Elshafie SS, Almaslamani M, et al. Epidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based study. Travel Med Infect Dis. 2010;8:377-387.
3. Marchaim D, Zaidenstein R, Lazarovitch T, et al. Epidemiology of bacteremia episodes in a single center: increase in Gram-negative isolates, antibiotics resistance, and patient age. Eur J Clin Microbiol Infect Dis. 2008;27:1045-1051.
4. Blot S, Vandewoude K, De Bacquer D, et al. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis. 2002;34:1600-1606.
5. Doit C, Mariani-Kurkdjian P, Mahjoub-Messai F, et al. Epidemiology of pediatric community-acquired bloodstream infections in a children hospital in Paris, France, 2001 to 2008. Diagn Microbiol Infect Dis. 2010;66:332-335.
6. Kang CI, Kim SH, Park WB, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49:760-766.
7. Vonberg R P, Wolter A, Chaberny IF, et al. Epidemiology of multi-drug-resistant gram-negative bacteria: data from an university hospital over a 36-month period. Int J Hyg Environ Health. 2008;211:251-257.
8. Kim YK, Pai H, Lee HJ, et al. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother. 2002;46:1481-1491.
9. Marschall J, Fraser VJ, Doherty J, et al. Between community and hospital: healthcare-associated gram-negative bacteremia among hospitalized patients. Infect Control Hosp Epidemiol. 2009;30:1050-1056.
10. Ullah F, Malik SA, Ahmed J. Antimicrobial susceptibility and ESBL prevalence in Pseudomonas aeruginosa isolated from burn patients in the North West of Pakistan. Burns. 2009;35:1020-1025.
11. Waters V, Larson E, Wu F, et al. Molecular epidemiology of gram-negative bacilli from infected neonates and health care workers' hands in neonatal intensive care units. Clin Infect Dis. 2004;38:1682-1687.
12. Zaki Mel S. Extended spectrum beta-lactamases among gram-negative bacteria from an Egyptian pediatric hospital: a two-year experience. J Infect DevCtries. 2007;1:269-274.
13. Al-Hasan MN, Huskins WC, Lahr BD, et al. Epidemiology and outcome of Gram-negative bloodstream infection in children: a population-based study. Epidemiol Infect. 2011;139:791-796.
14. Levy I, Leibovici L, Drucker M, et al. A prospective study of Gram-negative bacteremia in children. Pediatr Infect Dis J. 1996;15:117-122.
15. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-140.
16. Magiorakos A P, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268-281.
17. Bradford PA, Bratu S, Urban C, et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis. 2004;39:55-60.
18. Poirel L, Walsh TR, Cuvillier V, et al. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70:119-123.
19. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, Sweden: ECDC; 2013. doi: 10.2900/93403.
20. Karakoc C, Tekin R, Yeşilbaʇ Z, et al. Risk factors for mortality in patients with nosocomial Gram-negative rod bacteremia. Eur Rev Med Pharmacol Sci. 2013;17:951-957.
21. Laupland KB, Gregson DB, Vanderkooi OG, et al. The changing burden of pediatric bloodstream infections in Calgary, Canada, 2000-2006. Pediatr Infect Dis J. 2009;28:114-117.
22. Al-Hasan MN, Eckel-Passow JE, Baddour LM. Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study: healthcare-associated Gram-negative BSI. Eur J Clin Microbiol Infect Dis. 2012;31:1163-1171.
23. Raymond D P, Pelletier SJ, Crabtree TD, et al. Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients. Crit Care Med. 2003;31:1035-1041.
24. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309-317.
25. Maltezou HC, Kontopidou F, Katerelos P, et al. Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children. Pediatr Infect Dis J. 2013;32:e151-e154.
26. de Kraker ME, Davey PG, Grundmann H; BURDEN study group. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011;8:e1001104.
27. de Kraker ME, Wolkewitz M, Davey PG, et al. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to thirdgeneration cephalosporins. J Antimicrob Chemother. 2011;66:398-407.
28. Lambert ML, Suetens C, Savey A, et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis. 2011;11:30-38.
29. Marchaim D, Gottesman T, Schwartz O, et al. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 2010;54:5099-5104.
30. Willmann M, Kuebart I, Vogel W, et al. Time to positivity as prognostic tool in patients with Pseudomonas aeruginosa bloodstream infection. J Infect. 2013;67:416-423.